The company recently received a $25.00K grant investment on 31 March 2022, with the funding coming from the New Mexico Economic Development Department. TNeuroPharma operates within the Biotechnology and Health Care industries, positioning itself at the forefront of pioneering advancements in the early detection and treatment of Alzheimer's disease.
T-NeuroPharma
Using T-Cells to Track and Treat Neurodegenerative Diseases
Founded 2018
Albuquerque, United States
6 employees
Grant
Total: $25.00K
Biotechnology, Health Care +1
Albuquerque, United States
6 employees
Grant
Total: $25.00K
Biotechnology, Health Care +1
General Information
Company Name
T-NeuroPharma
Founded Year
2018
Location
Albuquerque, United States
Albuquerque, United States
Employees
6
Industries
Biotechnology, Health Care, Health and Wellness
Funding Stage
Grant
BounceWatch is an independent company data service, not affiliated with T-NeuroPharma. To contact T-NeuroPharma, visit tneuropharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About T-NeuroPharma
Taxonomy: Alzheimer's disease, T-cell technology, Neurodegenerative diseases, Therapeutic technology, Early detection, Blood samples, Treatment technology, Healthcare innovation, Medical technology, Albuquerque, New Mexico, Healthtech, Innovative therapies
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $25.00K | 1 |
New Mexico Economic Development Department
|
31 Mar 2022 |
| Seed Round | Undisclosed | 1 |
|
18 May 2021 |
T-NeuroPharma Alternatives & Competitors
View All Alternatives
T-NeuroPharma vs
ADmit Therapeutics
Spain
Identification of an early Alzheimer's disease will accelerate the identification of curative drugs
Venture round
13 employees
Biotechnology, Health Care
T-NeuroPharma vs
Cognoptix
United States
The Eye Scan for Alzheimer's Early Insight
Venture round
3 employees
Biotechnology, Health Care
T-NeuroPharma vs
Pioneering advancements in neuropsychiatric treatment for a brighter future
Series B
11-50 employees
Biotechnology, Health Care
FAQ About T-NeuroPharma
Using T-Cells to Track and Treat Neurodegenerative Diseases
T-NeuroPharma was founded in 2018.
T-NeuroPharma is headquartered in Albuquerque, United States.
T-NeuroPharma operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Alzheimer's disease, T-cell technology, Neurodegenerative diseases and Therapeutic technology.
T-NeuroPharma has approximately 6 employees.
T-NeuroPharma has completed 2 funding rounds, raising a total of $25.00K. The latest funding stage is Grant.
Top alternatives and competitors to T-NeuroPharma include ADmit Therapeutics, Cognoptix, Chase Pharmaceuticals, Alector, CaSRevolution. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
T-NeuroPharma and ADmit Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for T-NeuroPharma, https://bouncewatch.com/company/tneuropharma, updated 30 December 2024. When citing, please name BounceWatch and link this page.
